Last month pharmaceutical giant Merck has submitted their new drug Molnupiravir to the FDA for emergency approval ‘because Covid’. Most people thought this would be an ivermectin knock-off that would get approved and get all the glory ivermectin should have been getting all along. But it’s not that. It’s worse. Much worse. Far from being a simple anti-viral like its predecessors, Molnupiravir works by incorporating itself into the genetic material of viruses, and then causing a huge number of mutations as the virus replicates, effectively killing it. That’s all well and good, but how do they keep the drug from …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr